Zobrazeno 1 - 10
of 170
pro vyhledávání: ''
Autor:
Camilo R Gomez, Nitish Kumar, Fawad Ishfaq, Farhan Siddiq, Iryna Lobanova, Adnan I Qureshi, Wei Huang, Premkumar Nattanmai, Niraj Arora, Tariq Hamid, Kathryn Qualls
Publikováno v:
Stroke. 52
Background: Histamine (H) 2 blockers led to a significant increase of the relative bioavailability of nimodipine and therefore may change tolerability of nimodipine in patients with aneurysmal subarachnoid hemorrhage (SAH). Objective: To determine th
Autor:
Steven M. Greenberg, Gregoire Boulouis, Paul Fischer, Isra Tamim, Matthias Endres, Matthew P. Frosch, Frieder Schlunk, Brian J. Bacskai, Cenk Ayata, Maximilian Böhm, Michal Arbel, Tao Qin
Publikováno v:
Stroke
Background and Purpose— Mechanisms contributing to acute hematoma growth in intracerebral hemorrhage are not well understood. Neuropathological studies suggest that the initial hematoma may create mass effect that can tear vessels in the vicinity b
Autor:
Lisa J Woodhouse, Asita de Silva, Christopher Chen, Panos Koumellis, Jennifer L. Becker, Szabolcs Szatmári, Kennedy R. Lees, Philip M.W. Bath, John Gommans, George Ntaios, Nikola Sprigg, Stuart J. Pocock, Stephen J. Phillips, Alessandro Adami, Robert A. Dineen, Şerefnur Öztürk, Ronan Collins, Ana M. Casado, Anna Członkowska, Valeria Caso, Eivind Berge, Lesley Cala, Kailash Krishnan, Joanna M. Wardlaw, Polly Scutt, Hanna Christensen
Publikováno v:
Krishnan, K, Scutt, P, Woodhouse, L, Adami, A, Becker, JL, Berge, E, Cala, L, Casado, A, Caso, V, Chen, C, Christensen, H, Collins, R, Czlonkowska, A, Lees, K R, Ntaios, G, Ozturk, S, Phillips, S J, Pocock, S J, de Silva, A, Sprigg, N, Szatmari, S, Wardlaw, J & Bath, P M W 2015, ' Glyceryl Trinitrate for Acute Intracerebral Hemorrhage. Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis ', Stroke . https://doi.org/10.1161/STROKEAHA.115.010368
WOS: 000367136500008
PubMed: 26645254
Background and Purpose The Efficacy of Nitric Oxide in Stroke (ENOS) trial found that transdermal glyceryl trinitrate (GTN, a nitric oxide donor) lowered blood pressure but did not improve functional ou
PubMed: 26645254
Background and Purpose The Efficacy of Nitric Oxide in Stroke (ENOS) trial found that transdermal glyceryl trinitrate (GTN, a nitric oxide donor) lowered blood pressure but did not improve functional ou
Autor:
Mathew J. Reeves, Deepak L. Bhatt, Lee H. Schwamm, Ying Xian, Li Liang, Roland A. Matsouaka, Taku Inohara, Eric E. Smith, Adrian F. Hernandez, Gregg C. Fonarow, Eric D. Peterson, Jeffrey L. Saver
Publikováno v:
Stroke. 49
Background: The impact of the preceding use of concomitant use of antiplatelet and anticoagulation therapies on outcomes of intracerebral hemorrhage (ICH) has not been thoroughly investigated. Methods: We analyzed 138,834 patients presenting with ICH
Autor:
Eiichi Nomura, Yuji Shiga, Masakazu Nishigaki, Michiyoshi Sato, Masaru Kuriyama, Shinichi Takeshima
Publikováno v:
Stroke. 48
Background and Hypothesis: The effectiveness and safety of anticoagulants, which are widely used for preventing stroke recurrence, in stroke prevention is well established, they rarely cause severe adverse events, such as intracerebral hemorrhage (IC
Autor:
Yoshinobu Kamio, Kazuha Mitsui, Hajime Furukawa, Kimihiko Yokosuka, Dingding Zhang, Masaaki Korai, Tomoki Hashimoto
Publikováno v:
Stroke. 48
Background: Nicotine is one of main chemicals of tobacco smoke and promotes atherosclerosis and stroke. Tobacco smoke is considered an independent risk factor for intracranial aneurysm formation, growth, and rupture. There are mainly 5 subtypes of ni
Publikováno v:
Stroke. 48(7)
Background and Purpose— Targeting the prostaglandin I 2 prostanoid (IP) receptor to reduce stroke injury has been hindered by the lack of selective drugs. MRE-269 is the active metabolite of selexipag showing a high selectivity toward the IP recept
Publikováno v:
Stroke. 48(5)
In patients taking oral anticoagulants (OACs), the annual rate of intracranial hemorrhage is 0.3% to 0.6%. Of these bleeds, 46% to 86% are intracerebral; 13% to 45% are subdural, and 1% to 8% are subarachnoidal.1,2 With 30- to 90-day mortality rates
Autor:
John H. Zhang, Paul R. Krafft, Nicole R. Van Allen, Jerry J. Flores, Damon Klebe, Richard Lee Applegate, William B. Rolland, Arthur Leitzke, Tim Lekic
Publikováno v:
Stroke, vol 44, iss 12
Background and Purpose— This study investigated whether isoflurane ameliorates neurological sequelae after germinal matrix hemorrhage (GMH) through activation of the cytoprotective sphingosine kinase/sphingosine-1-phosphate receptor/Akt pathway. Me
Autor:
Bertrand Lapergue, Jean-Baptiste Michel, Guadalupe Ortiz-Munoz, Liliane Louedec, Olivier Meilhac, Mikael Mazighi, Stéphane Loyau, Pierre Amarenco, Sandrine Delbosc, Jean-Philippe Desilles, Bao Quoc Dang, Pierre-Olivier Couraud
Publikováno v:
Stroke
Stroke; Vol 44
Stroke; Vol 44
Background and Purpose— We have previously reported that intravenous injection of high-density lipoproteins (HDLs) was neuroprotective in an embolic stroke model. We hypothesized that HDL vasculoprotective actions on the blood–brain barrier (BBB)